Printer Friendly

Negative pressure wound therapy tied to complications.

The Food and Drug Administration has warned clinicians and patients to be vigilant for potentially life-threatening complications with the use of negative-pressure wound-therapy devices.

The agency issued the notification after receiving reports of 6 deaths and 77 injuries associated with NPWT devices. "Most of the deaths reported to FDA occurred at home or in a long-term care facility," the FDA said.

Bleeding was the most serious complication; it was involved in 6 deaths and 17 injuries. Infections, which played a role in 27 reports, arose from the original open wound or dressing pieces retained in the wound. Overall, 32 injuries involved retention of foam dressing pieces; most of those patients required surgical procedures, wound debridement, and treatment of wound dehiscence, as well as additional hospitalization and antibiotic therapy.

The FDA notice listed wound types and conditions for which NPWT is con-traindicated as well as risk factors that should be considered before NPWT is used. (See boxes.)

NPWT is still useful "in the appropriate wounds and in the appropriate areas," said Dr. Paul Y. Takahashi, an internist and expert in wound care at the Mayo Clinic, Rochester, Minn.

The device is FDA approved and "can help, particularly with preventing amputations. It can help in some situations in which a flap or a skin graft is not appropriate. And it certainly can still be beneficial for wounds that are not healing," he said in an interview. But "you really have to be well trained in using the negative pressure device, and when you remove it ... make sure it's well observed, make sure things are healing in nicely and that you're not having excess bleeding."

Unlike standard wound dressings, which are changed at least daily, NPWT dressings may not be changed for 3 or 4 days, so complications can go unnoticed in NPWT-treated wounds, he noted.

Staff and patients should be alert for certain problem signs, Dr. Takahashi said. The edges of the wound should remain pink. It's time to become concerned when the edges start turning red or the area becomes painful. Other concerning symptoms include fevers, chills, and changes in blood pressure.

A patient handout and a link to the notification ConsumerUpdates/ucml 93277.htm.

Risk Factors Relevant to NPWT Use

* Patients at high risk for bleeding and hemorrhage

* Patients on anticoagulants or platelet-aggregation inhibitors

* Patients with:

Friable vessels and infected blood vessels

Vascular anastomosis

Infected wounds

Osteomyelitis

Exposed organs, vessels, nerves, tendon, and ligaments

Sharp edges in the wound (e.g., bone fragments)

Spinal cord injury (stimulation of sympathetic nervous system) Enteric fistulas

* Patients requiring:

MRI

Hyperbaric chamber

Defibrillation

* Patient size and weight

* Use near vagus nerve (bradycardia)

* Application of circumferential dressing

* Mode of therapy--intermittent versus continuous negative pressure

Source: Food and Drug Administration

Contraindications For NPWT

Necrotic tissue with eschar present

Untreated osteomyelitis

Nonenteric and unexplored fistulas

Malignancy in the wound

Exposed vasculature

Exposed nerves

Exposed anastomotic site

Exposed organs

Source: Food and Drug Administration
COPYRIGHT 2010 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Finn, Robert
Publication:Internal Medicine News
Geographic Code:1USA
Date:Feb 1, 2010
Words:486
Previous Article:FDA finds no cancer link for ezetimibe or simvastatin.
Next Article:Colonoscopy lowers ca risk on left side only.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters